Get started
Author

Lawrence A. Hill

Observed names: L A Hill, Lawrence A Hill, Lawrence Hill
ORCID: 0000-0002-9147-0934
Observed ORCID: 0000-0002-9147-0934
OpenAlex ID: A5037831869
Rapid Efficacy of the Highly Selective α1A-Adrenoceptor Antagonist Silodosin in Men With Signs and Symptoms of Benign Prostatic Hyperplasia: Pooled Results of 2 Phase 3 Studies
2012 · Leonard S. Marks, Marc C. Gittelman, et al. · The Journal of Urology · 161
Rapid Efficacy of the Highly Selective α1A-Adrenoceptor Antagonist Silodosin in Men With Signs and Symptoms of Benign Prostatic Hyperplasia: Pooled Results of 2 Phase 3 Studies
2009 · Leonard S. Marks, Marc C. Gittelman, et al. · The Journal of Urology · 143
Silodosin for Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Results of a Phase II Multicenter, Double-Blind, Placebo Controlled Study
2011 · J. Curtis Nickel, Michael P. O'Leary, et al. · The Journal of Urology · 70
Silodosin in the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia: A 9-Month, Open-label Extension Study
2009 · Leonard S. Marks, Marc C. Gittelman, et al. · Urology · 67
Lack of Pharmacodynamic Interaction of Silodosin, a Highly Selective α1a-Adrenoceptor Antagonist, With the Phosphodiesterase-5 Inhibitors Sildenafil and Tadalafil in Healthy Men
2010 · Scott A. MacDiarmid, Lawrence A. Hill, et al. · Urology · 32
Silodosin for the Treatment of Benign Prostatic Hyperplasia: Pharmacology and Cardiovascular Tolerability
2010 · Herbert Lepor, Lawrence A. Hill · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 28
Effects of the Selective α1A-Adrenoceptor Antagonist Silodosin on ECGs of Healthy Men in a Randomized, Double-Blind, Placebo- and Moxifloxacin-Controlled Study
2010 · J Morganroth, H Lepor, et al. · Clinical Pharmacology & Therapeutics · 22
The QT Interval and Selection of Alpha-Blockers for Benign Prostatic Hyperplasia.
2008 · Herbert Lepor, Norman E Lepor, et al. · Europe PMC (PubMed Central) · 8
Effect of estimated prostate volume on silodosin-mediated improvements in the signs and symptoms of BPH: does prostate size matter?
2011 · Kaplan, Claus Roehrborn, et al. · Research and Reports in Urology · 4
PDF
1433 Effects of Silodosin in Men With Moderate or Severe Chronic Prostatitis/chronic Pelvic Pain Syndrome: a Double-blind, Placebo-controlled Phase 2 Study
2011 · J. Curtis Nickel, Michael O'Leary, et al. · The Journal of Urology · 3
Effect of silodosin on specific urinary symptoms associated with benign prostatic hyperplasia: analysis of international prostate symptom scores in 2 phase III clinical studies
2010 · Gittelman, Leonard S. Marks, et al. · Research and Reports in Urology · 3
PDF
Effect of silodosin on specific urinary symptoms associated with benign prostatic hyperplasia: analysis of international prostate symptom scores in 2 phase III clinical studies
2010 · Marc Gittelman, Leonard S. Marks, et al. · Research and Reports in Urology · 2
Rapid Response of Irritative and Obstructive Urinary Symptoms of Benign Prostatic Hyperplasia to Treatment With Silodosin in 2 Randomized Studies
2009 · Leonard S Marks, Marc C Gittelman, et al. · The Journal of Urology · 1
Poster 96 Long‐Term Safety Analysis of 3 mg/mL of Gablofen® (Baclofen Injection) Administered through Intrathecal Route
2015 · Yanping Zheng, Lisa Sisk, et al. · PM&R
Effect of estimated prostate volume on silodosin-mediated improvements in the signs and symptoms of BPH: does prostate size matter?
2011 · Steven Kaplan, Claus Roehrborn, et al. · Research and Reports in Urology
DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP STUDY TO DEFINE ELECTROCARDIOGRAPHIC EFFECTS OF SILODOSIN, A UROSELECTIVE α-ADRENERGIC ANTAGONIST
2008 · Herbert Lepor, Gary Hoel, et al. · The Journal of Urology
Works count: 16
Citation count: 544
H-index: 8
I10-index: 7
Year
Topic
Type